Page last updated: 2024-11-02

phenazopyridine and Urogenital Prolapse

phenazopyridine has been researched along with Urogenital Prolapse in 1 studies

Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sierra, T1
Taylor, DL1
Leung, K1
Hall, CD1
Flynn, MK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials[NCT03065075]Phase 3152 participants (Actual)Interventional2017-02-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Postoperative Urinary Retention After Pelvic Organ Prolapse Surgery (AS-TREATED)

Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1

InterventionParticipants (Count of Participants)
Phenazopyridine28
No Phenazopyridine27

Number of Participants With Postoperative Urinary Retention After Pelvic Organ Prolapse Surgery (INTENT-TO-TREAT)

Rate of postoperative urinary retention after pelvic organ prolapse surgery as determined by those who failed a standardized void trial. A successful void trial is defined as a postvoid residual of less than half of the voided volume. (NCT03065075)
Timeframe: postoperative day 1

InterventionParticipants (Count of Participants)
Phenazopyridine30
No Phenazopyridine25

Trials

1 trial available for phenazopyridine and Urogenital Prolapse

ArticleYear
The Effect of Phenazopyridine on Immediate Postoperative Voiding After Prolapse Surgery: A Randomized Controlled Trial.
    Female pelvic medicine & reconstructive surgery, 2021, 02-01, Volume: 27, Issue:2

    Topics: Anesthetics; Female; Humans; Middle Aged; Pelvic Organ Prolapse; Phenazopyridine; Postoperative Care

2021